Vetter a winner of the Fraunhofer Clean Manufacturing Award CLEAN! 2018
Dr.-Ing. Udo Gommel (left), Head of Department Fraunhofer IPA hands over the clean manufacturing award CLEAN! 2018 to Dr. Ute Schleyer, Project Manager Plant and Site Development at Vetter.
Vetter innovations in aseptic production increases the competitiveness of its customers.
Vetter is one of the winners of the clean manufacturing award CLEAN! 2018. The pharmaceutical service provider was able to convince the independent expert jury of the Fraunhofer Institute for Manufacturing Engineering and Automation (IPA) with its innovative Vetter CleanRoom Technology V-CRT. The prize was awarded as part of the LOUNGES 2018, an associated trade event in the clean manufacturing sector.
With the CLEAN! award, the Fraunhofer IPA honors groundbreaking developments in clean technology. "The production of active pharmaceutical ingredients, microchips or nanoproducts would be unthinkable without a high-purity manufacturing environment," says Dr.-Ing. Udo Gommel, Head of Department Fraunhofer IPA. "Vetter drives innovations in aseptic production and thereby increases the competitiveness of its customers. This achievement is honored by the Fraunhofer clean manufacturing award CLEAN! 2018." Important award and evaluation criteria included innovation leap, sustainability and industrial feasibility of the application concept. The Fraunhofer IPA is an institution of the Fraunhofer-Gesellschaft, Munich, that promotes applied research. It is particularly concerned with the development of sustainable and pioneering products.
Bernd Stauss, Senior Vice President Production/Engineering at Vetter, says: "We continue to develop our technologies to meet the complex and ever-increasing demands for quality and flexibility in pharmaceutical manufacturing. We are very pleased that this has now been honored with the Fraunhofer clean manufacturing award CLEAN! 2018 for our cleanroom concept V-CRT."
V-CRT is a holistic manufacturing technology developed by Vetter for the safe aseptic filling of injection systems. The innovative approach combines the advantages of isolators with Restricted Access Barrier Systems (RABS) and is based on the idea of fully automated decontamination of the entire cleanroom with hydrogen peroxide (H2O2). The result is the highest possible safety in the prevention of contamination as well as a flexible production process. Following the successful commercial implementation and validation of V-CRT in 2017, the technology will be used in all cleanrooms at Vetter by 2025.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.